Study Evaluating the Safety and Effectiveness of Etanercept for the Treatment of Pediatric Psoriasis

CompletedOBSERVATIONAL
Enrollment

72

Participants

Timeline

Start Date

November 19, 2010

Primary Completion Date

September 24, 2018

Study Completion Date

September 24, 2018

Conditions
Psoriasis
Interventions
DRUG

Etanercept

Expected duration of 24 weeks as one course

Trial Locations (29)

1089

Heim Pal Children's Hospital, Budapest

10117

Charite Universitaetsmedizin Berlin, Berlin

16121

Andreas Syngros Hospital, Athens

University of Athens, Andreas Syngros Hospital, Athens

28046

Hospital Universitario La Paz, Madrid

29000

CH Quimper Cornouaille, Quimper

35128

University of Padova, Padua

37170

CHRU Tours Hopital Trousseau, Chambray-lès-Tours

44093

CHU de Nantes - Hôtel Dieu, Nantes

45122

Universitätsklinikum Essen, Essen

50937

Universitaetsklinik Koeln, Cologne

53757

Kath. Kinderkrankenhaus Wilhelmstift, Hamburg

Asklepios Klinik Sankt Augustin GmbH, Sankt Augustin

54643

Skin and Venereal Diseases' Hospital, Thessaloniki

55101

Kinderklinik der Johannes-Gutenberg Universitat Mainz, Mainz

60590

J W Goethe Universitaet Frankfurt, Frankfurt am Main

80131

Universita degli Studi di Napoli Federico II, Napoli

Universita degli Studi di Napoli, Napoli

90127

ARNAS Civico Di Gristina M Ascoli, Palermo

91052

Hautklinik Universitaetsklinikum Erlangen, Erlangen

95107

Centre Hospitalier Victor Dupouy / Service de Dermatologie, Argenteuil

01307

Universitaetsklinik Carl Gustav Carus, Dresden

00168

Università Cattolica del Sacro Cuore Policlinico A., Roma

04019

Ospitale Alfredo Fiorini, Terracina

6500 HB

UMC St Radbound, Nijmegen

3000 CA

Erasmus MC, Rotterdam

1649-028

Hospital Santa Maria, Lisbon

08025

Hospital de la Santa Cruz y San Pablo, Barcelona

08208

Hospital Parc Tauli, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY